Literature DB >> 15191867

Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.

Takanori Yoshida1, Toshifumi Matsumoto, Atsushi Sasaki, Kohei Shibata, Masanori Aramaki, Seigo Kitano.   

Abstract

BACKGROUND: This retrospective study aimed to identify the clinicopathologic features and surgical results of paraaortic node-positive periampullary adenocarcinoma.
METHODS: Between 1995 and 1999, 101 patients underwent pancreatectomy with regional and paraaortic lymphadenectomy. Fifteen (15%) patients had histologically proven paraaortic lymph node disease.
RESULTS: The 15 patients included 9 (26%) of 34 patients with pancreatic head carcinoma and 6 (17%) of 36 patients with bile duct adenocarcinoma. All 15 patients had locally advanced tumor invading adjacent structures. The 1-, 2-, and 3-year survival rates were 33%, 27%, and 0%, with median survival of 12 months (range 3 to 33). In patients with pancreatic head carcinoma or bile duct adenocarcinoma, survival curve for those without paraaortic lymph node metastasis was significantly better than that for those with involved paraaortic lymph nodes (P = 0.0033 or P = 0.0149).
CONCLUSIONS: When the paraaortic lymph nodes obtained from sampling biopsy are histologically positive, radical pancreatectomy with extended lymphatic and soft tissue clearance should be abandoned owing to poor outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15191867     DOI: 10.1016/j.amjsurg.2003.07.031

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  26 in total

1.  Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Yoshio Yuasa; Taijiro Sueda
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

2.  Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.

Authors:  Hisashi Imai; Ryuichiro Doi; Hiroyuki Kanazawa; Naoko Kamo; Masayuki Koizumi; Toshihiko Masui; Yasuhiro Iwanaga; Yoshiya Kawaguchi; Yasutsugu Takada; Hiroyoshi Isoda; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2010-03-16       Impact factor: 3.402

3.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

Review 4.  Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?

Authors:  Sunny Y Wong; Richard O Hynes
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

5.  Accomplishments in 2007 in the management of hepatobiliary cancers.

Authors:  Anthony T C Chan; Yoji Kishi; Stephen L Chan; Jean-Nicolas Vauthey
Journal:  Gastrointest Cancer Res       Date:  2008-05

6.  Comparison of CT and MRI for presurgical characterization of paraaortic lymph nodes in patients with pancreatico-biliary carcinoma.

Authors:  Young-Chul Kim; Mi-Suk Park; Seung-Whan Cha; Yong-Eun Chung; Joon-Suk Lim; Kyung-Sik Kim; Myeong-Jin Kim; Ki-Whang Kim
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 7.  Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features.

Authors:  Christos Agalianos; Nikolaos Gouvas; Kleo Papaparaskeva; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2016-06-03       Impact factor: 3.647

Review 8.  Pancreatic cancer: diagnosis and treatments.

Authors:  Hong-Yu Li; Zhong-Min Cui; Jiang Chen; Xiao-Zhong Guo; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-02-14

Review 9.  Staging of extrahepatic cholangiocarcinoma.

Authors:  Yong Eun Chung; Myeong-Jin Kim; Young Nyun Park; Yoon-Hee Lee; Jin-Young Choi
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

10.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.